


Respiratory Trainee - interested in Immunology, Infectious Disease, Critical Care. Lover of festivals/music/art. ILD Fellow SCGH, Perth 2024 🇦🇺


This #Movember I am pleased to announce a major milestone towards our National Registry for #TesticularCancer #Survivors #SLECT trial now approved by R&I in @stjamesdublin and @CancerInstIRE Hoping to expand to other cancer centre in coming weeks

Approved today: the first ever approved therapy for bronchiectasis in Europe Congratulations investigators, patients and Insmed Science changes lives European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union - Nov 18, 2025 investor.insmed.com/2025-11-…

Now THAT is a prescribing cascade @CarolynTanMD

Today I learned that sometimes hepatocellular carcinoma can be diagnosed on imaging alone. If the patient has cirrhosis, chronic hep B or prior HCC an LI-RADS score of 5 is diagnostic! LI-RADS 4 requires biopsy and LI-RADS 3 or less is likely benign and can be monitored.

A new paper published in The Lancet — one of the world's most respected health journals — finds that sanctions imposed by the West on developing countries have caused *38 million deaths* since 1971.

Does mental stress affect our mitochondria? In this new paper, we asked if 5 minutes of mental stress (public speaking) changed the amount of cell-free mitochondrial DNA (cf-mtDNA) Absolute saliva cf-mtDNA levels increased on average by 280% after mental stress! 🧵

Is this the end of rivaroxaban for acute VTE? @LanaCastellucci presenting the COBBRA trial - 1st RCT comparing apixaban to riva over 3 months. 56% reduction in bleeding risk with apixaban. A safer Rx with the same efficacy. #ISTH2025

Great news! The CHORUS Trial is now open to recruitment, congratulations to @PilarRiveraOrt1 and her team for being the first site to open. @RoyalDevonNHS Excited to get started 🎉📷 @ActionPFcharity

ERJOR: A walk test of 3 min still detects most desaturation events with equivalent prognostic value. Shorter walk tests could be used clinically, which would be a more efficient and patient-centred approach and also help the move towards remote monitoring. bit.ly/43rebnv

Today, I spoke @NorthwesternMed Grand Rounds on “The Price of Progress” - a reminder our excitement post-#ASCO25 should be tempered by reality: 🧾 33% of pts spend their life savings within 2 yrs of a cancer dx 🧠 50% experience financial distress 💼 75% leave the workforce

Find all TAPS (The Australasian Pleural Seminars): 15min @ on youtube.com/@TheAustralasian… Or go straight to the latest from @e_fysh on Pleural Effusion in Intensive Care on youtube.com/watch?v=XtFksPUU… Enjoy! @PleuralPOCUS @UKPleura @ALATorax @aabip @tsanz_thoracic @TOGAANZ @APSRapsr @accpchest @NCARD_research @uwanews @PulmPEEPs @iPulmOG

Such an accurate statement!!
Chronically renaming diseases is a great way for academics to feel important and for patients and most clinicians to feel confused.

Wow! What a day for #CureIPF & #ATS2025! First positive drug trial in 10 years in IPF!! Treatment with Nerandomilast -> ⬇️FVC decline compared to placebo in patients on antifibrotics or untreated. Kudos Drs Richeldi and Wijsenbeek and #FibroneerIPF team nejm.org/doi/full/10.1056/NE…

Breathe: This review summarises interesting insights into interstitial lung disease pathogenesis from a translational science point of view @3Assembly @ERSpublications @EuroRespSoc @EarlyCareerERS @SaraOcana1 bit.ly/4iRjP8s

Clinical Statement: Medical management of inpatients with tobacco dependency. @BTSrespiratory @ThoraxBMJ thorax.bmj.com/content/79/Su… @AshOrgUK @asthmalunguk